Neuroreceptors and neuromediators

Pruritus

Volumn , Issue , 2010, Pages 7-15

  Ständer, Sonja ^a   Luger, Thomas A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879686809     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-322-8_2     Document Type: Chapter

References (117)

1. Abadia Molina F, Burrows NP, Jones RR, et al. Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis. Br J Dermatol. 1992;127:344-351.
2. Ahluwalia J, Urban L, Capogna M, et al. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience. 2000;100:685-688.
3. Albers KM, Woodbury CJ, Ritter AM, et al. Glial cell-linederived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors. J Neurosci. 2006;26:2981-2990.
4. Amaya F, Shimosato G, Kawasaki Y, et al. Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist. Pain. 2006;124:175-183.
5. Bigliardi PL, Stammer H, Jost G, Rufli T, Büchner S, Bigliardi-Qi M. Treatment of pruritus with topically applied opiate receptor antagonist. J Am Acad Dermatol. 2007;56:979-988.
6. Bell JK, McQueen DS, Rees JL. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol. 2004;142:374-380.
7. Bernstein JE, Swift RM. Relief of intractable pruritus with naloxone. Arch Dermatol. 1979;115:1366-1367.
8. Bernstein JE, Grinzi RA. Butorphanol-induced pruritus antagonized by naloxone. J Am Acad Dermatol. 1981;5:227-228.
9. Botchkarev VA, Yaar M, Peters EM, et al. Neurotrophins in skin biology and pathology. J Invest Dermatol. 2006;126:1719-1727.
10. Bowles WR, Sabino M, Harding-Rose C, et al. Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin-sensitive cutaneous neurons. Neurosci Lett. 2006;403:305-308.
11. Bromm B, Scharein E, Darsow U, et al. Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett. 1995;187:157-160.
12. Chateau Y, Misery L Connections between nerve endings and epidermal cells: are they synapses? Exp Dermatol. 2004;13:2-4.
13. Chung MK, Lee H, Caterina MJ. Warm temperatures activate TRPV4 in mouse 308 keratinocytes. J Biol Chem. 2003;278:32037-32046.
14. Chung MK, Lee H, Mizuno A, et al. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytes. J Biol Chem. 2004;279:21569-1575.
15. Church MK, el-Lati S, Caulfield JP. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol. 1991;94:310-318.
16. Coutts AA, Irving AJ, Mackie K, et al. Localisation of cannabinoid CB (1) receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol. 2002;448:410-422.
17. Dallos A, Kiss M, Polyanka H, et al. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides. 2006;40:251-263.
18. De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P, Di Marzo V. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther. 2008;325:1007-1015.
19. Denda M, Sokabe T, Fukumi-Tominaga T, et al. Effects of skin surface temperature on epidermal permeability barrier homeostasis. J Invest Dermatol. 2007;127:654-659.
20. Devane WA, Dysarz FA 3rd, Johnson MR, et al. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988;34:605-613.
21. Ding-Pfennigdorff D, Averbeck B, Michaelis M. Stimulation of PAR-2 excites and sensitizes rat cutaneous C-nociceptors to heat. Neuroreport. 2004;15:2071-2075.
22. Dou YC, Hagstromer L, Emtestam L, et al. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res. 2006;298:31-37.
23. Dvorak M, Watkinson A, McGlone F, et al. Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res. 2003;52:238-245.
24. Yaping E, Golden SC, Shalita AR, et al. Neuropeptide (calcitonin gene-related peptide) induction of nitric oxide in human keratinocytes in vitro. J Invest Dermatol. 2006;126:1994-2001.
25. Elitt CM, McIlwrath SL, Lawson JJ, et al. Artemin overexpression in skin enhances expression of TRPV1 and TRPA1 in cutaneous sensory neurons and leads to behavioral sensitivity to heat and cold. J Neurosci. 2006;26:8578-8587.
26. Facci L, Dal Toso R, Romanello S, et al. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA. 1995;92:3376-3380.
27. Farquhar-Smith WP, Rice AS A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology. 2003;99:1391-1401.
28. Fattore L, Cossu G, Spano MS, et al. Cannabinoids and reward: interactions with the opioid system. Crit Rev Neurobiol. 2004;16:147-158.
29. Fjellner B, Hägermark O. Potentiation of histamine-induced itch and flare response in human skin by the enkephalin analogue FK 33-824, beta-endorphin and morphine. Arch Dermatol Res. 1982;274:29-37.
30. Galiegue S, Mary S, Marchand J, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem. 1995;232:54-61.
31. Gaudillere A, Misery L, Souchier C, et al. Intimate associations between PGP9.5-positive nerve fibres and Langerhans cells. Br J Dermatol. 1996;135:343-344.
32. Gibran NS, Jang YC, Isik FF, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res. 2002;108:122-128.
33. Gray EG. Electron microscopy of presynaptic organelles of the spinal cord. J Anat. 1963;97:101-106.
34. Hara M, Toyoda M, Yaar M, et al. Innervation of melanocytes in human skin. J Exp Med. 1996;184:1385-1395.
35. Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev. 1990;42:45-83.
36. Hilliges M, Wang L, Johansson O. Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J Invest Dermatol. 1995;104:134-137.
37. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature. 1993;363:159-163.
38. Huang JF, Thurmond RL. The new biology of histamine receptors. Curr Allergy Asthma Rep. 2008;8:21-27.
39. Hu HJ, Bhave G, Gereau RW 4th. Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. J Neurosci. 2002;22:7444-7452.
40. Ibrahim MM, Porreca F, Lai J, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA. 2005;102(8):3093-3098.
41. Ikoma A, Steinhoff M, Ständer S, et al Neurobiology of pruritus. Nat Rev Neurosci. 2006;7:535-547.
42. Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tüting T, Zimmer A. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 2007;316:1494-1497.
43. Kim JC, Kim DB, Seo SI, Park YH, Hwang TK. Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats. BJU Int. 2004;94:915-918.
44. Johansson O, Liang Y, Emtestam L Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin - an exploration of the cause of neurohyperplasia. Arch Dermatol Res. 2002;293:614-619.
45. Jordt SE, Bautista DM, Chuang HH, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature. 2004;427:260-265.
46. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413:203-210.
47. Kanda N, Watanabe S Histamine enhances the production of nerve growth factor in human keratinocytes. J Invest Dermatol. 2003;121:570-577.
48. Katugampola R, Church MK, Clough GF. The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo. Exp Physiol. 2000;85:839-846.
49. Ko MC, Naughton NN. An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology. 2000;92:795-805.
50. Lee H, Caterina MJ. TRPV channels as thermosensory receptors in epithelial cells. Pflugers Arch. 2005;451:160-167.
51. Lembeck F, Donnerer J, Bartho L. Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]-enkephalinamide. Eur J Pharmacol. 1982;85:171-176.
52. Lewis T, Grant RT, Marvin HM. Vascular reactions of the skin to injury. Heart. 1929;14:139-160.
53. Liang Y, Marcusson JA, Jacobi HH, et al. Histaminecontaining mast cells and their relationship to NGFrimmunoreactive nerves in prurigo nodularis: a reappraisal. J Cutan Pathol. 1998;25:189-198.
54. Lindfors PH, Voikar V, Rossi J, et al. Deficient nonpeptidergic epidermis innervation and reduced inflammatory pain in glial cell line-derived neurotrophic factor family receptor alpha2 knock-out mice. J Neurosci. 2006;26:1953-1960.
55. Malin SA, Molliver DC, Koerber HR, et al. Glial cell linederived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J Neurosci. 2006;26:8588-8599.
56. Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561-564.
57. Matsushima H, Yamada N, Matsue H, et al. The effects of endothelin-1 on degranulation, cytokine, and growth factor production by skin-derived mast cells. Eur J Immunol. 2004;34:1910-1919.
58. Maekawa T, Nojima H, Kuraishi Y, Aisaka K. The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis. Eur J Pharmacol. 2006;542:179-183.
59. Metz M, Lammel V, Gibbs BF, et al. Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. Am J Pathol. 2006;169:815-822.
60. Metze D, Reimann S, Beissert S, et al. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol. 1999;41:533-539.
61. Mohapatra DP, Nau C. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J Biol Chem. 2005;280:13424-13432.
62. Moormann C, Artuc M, Pohl E, et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol. 2006;126:746-755.
63. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61-65.
64. Nockher WA, Renz H. Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol. 2006;117:583-589.
65. Obata K, Katsura H, Mizushima T, et al. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest. 2005;115:2393-2401.
66. Obreja O, Rukwied R, Steinhoff M, et al. Neurogenic components of trypsin- and thrombin-induced inflammation in rat skin, in vivo. Exp Dermatol. 2006;15:58-65.
67. Ohkubo T, Shibata M, Inoue M, et al. Regulation of substance P release mediated via prejunctional histamine H3 receptors. Eur J Pharmacol. 1995;273:83-88.
68. Patapoutian A. TRP channels and thermosensation. Chem Senses. 2005;30(suppl 1):i193-i194.
69. Patwardhan AM, Jeske NA, Price TJ, et al. The cannabinoid WIN 55, 212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc Natl Acad Sci USA. 2006;103:11393-11398.
70. Paradisi A, Pasquariello N, Barcaroli D, Maccarrone M. Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J Biol Chem. 2008;283:6005-6012.
71. Peier AM, Reeve AJ, Andersson DA, et al. A heat-sensitive TRP channel expressed in keratinocytes. Science. 2002;296:2046-2049.
72. Pertwee RG. Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sci. 1999;65:597-605.
73. Quinlan KL, Song IS, Naik SM, et al. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. J Immunol. 1999;162:1656-1661.
74. Ray NJ, Jones AJ, Keen P. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br J Pharmacol. 1991;102:797-800.
75. Rukwied R, Watkinson A, McGlone F, et al. Cannabinoid agonists attenuate capsaicin-induced responses in human skin. Pain. 2003;102:283-288.
76. Sakurada T, Sakurada S, Katsuyama S, et al. Evidence that N-terminal fragments of nociceptin modulate nociceptininduced scratching, biting and licking in mice. Neurosci Lett. 2000;279:61-64.
77. Schmelz M, Schmidt R, Bickel A, et al. Innervation territories of single sympathetic C fibers in human skin. J Neurophysiol. 1998;79:1653-1660.
78. Schmelz M, Schmidt R, Weidner C, et al. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol. 2003;89:2441-2448.
79. Schuligoi R, Amann R. Differential effects of treatment with nerve growth factor on thermal nociception and on calcitonin gene-related peptide content of primary afferent neurons in the rat. Neurosci Lett. 1998;252:147-149.
80. Senba E, Katanosaka K, Yajima H, et al. The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers. Neurosci Res. 2004;50:257-262.
81. Shu X, Medell LM. Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. J Neurosci. 1998;18:8947-8959.
82. Singh LK, Pang X, Alexacos N, et al. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav Immun. 1999;13:225-239.
83. Ständer S, Metze D. Treatment of pruritic skin diseases with topical capsaicin. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F, eds. Itch: Basic Mechanisms and Therapy. New York: Marcel Dekker; 2004:287-304.
84. Ständer S, Schmelz M. Chronic itch and pain - similarities and differences. Eur J Pain. 2006;10:473-478.
85. Ständer S, Gunzer M, Metze D, et al. Localization of m-opioid receptor 1A on sensory nerve fibers in human skin. Regul Pept. 2002;110:75-83.
86. Ständer S, Steinhoff M, Schmelz M, et al. Neurophysiology of pruritus. cutaneous elicitation of itch. Arch Dermatol. 2003;139:1463-1470.
87. Ständer S, Moormann C, Schumacher M, et al. Expression of vanilloid receptor subtype 1 (VR1) in cutaneous sensory nerve fibers, mast cells and epithelial cells of appendage structures. Exp Dermatol. 2004;13:129-139.
88. Ständer S, Schmelz M, Metze D, et al. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci. 2005;38:177-188.
89. Ständer S, Reinhardt HW, Luger TA. Topische Cannabinoid-Agonisten: Eine effektive, neue Möglichkeit zur Behandlung von chronischem Pruritus. Hautarzt. 2006;57:801-807.
90. Ständer S, Ständer H, Seeliger S, et al. Topical pimecrolimus (SDZ ASM 981) and tacrolimus (FK 506) transiently induces neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol. 2007;156:1020-1026.
91. Stein C, Millan MJ, Shippenberg TS, et al. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther. 1989;248:1269-1275.
92. Steinhoff M, Vergnolle N, Young SH, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med. 2000;6:151-158.
93. Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci. 2003;23:6176-6180.
94. Steinhoff M, Stander S, Seeliger S, et al. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol. 2003;139:1479-1488.
95. Story GM, Peier AM, Reeve AJ, et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell. 2003;112:819-829.
96. Sugimoto Y, Iba Y, Nakamura Y, et al. Pruritus-associated response mediated by cutaneous histamine H3 receptors. Clin Exp Allergy. 2004;34:456-459.
97. Summerfield JA. Pain, itch and endorphins. Br J Dermatol. 1981;105:725-726.
98. Takashima Y, Daniels RL, Knowlton W, Teng J, Liman ER, McKemy DD. Diversity in the neural circuitry of cold sensing revealed by genetic axonal labeling of transient receptor potential melastatin 8 neurons. J Neurosci. 2007;27:14147-14157.
99. Thomsen JS, Sonne M, Benfeldt E, et al. Experimental itch in sodium lauryl sulphate-inflamed and normal skin in humans: a randomized, double-blind, placebo-controlled study of histamine and other inducers of itch. Br J Dermatol. 2002;146:792-800.
100. Togias A. H1-receptors: localization and role in airway physiology and in immune functions. J Allergy Clin Immunol. 2003;112(suppl):S60-S68.
101. Trentin PG, Fernandes MB, D'Orleans-Juste P, et al. Endothelin-1 causes pruritus in mice. Exp Biol Med (Maywood). 2006;231:1146-1151.
102. Ui H, Andoh T, Lee JB, et al. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol. 2006;530:172-178.
103. Vellani V, Colucci M, Lattanzi R, et al. Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8. J Neurosci. 2006;26:5109-5116.
104. Vigano D, Rubino T, Parolaro D. Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacol Biochem Behav. 2005;81:360-368.
105. Weidner C, Klede M, Rukwied R, et al. Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study. J Invest Dermatol. 2000;115:1015-1020.
106. Weller K, Foitzik K, Paus R, et al. Mast cells are required for normal healing of skin wounds in mice. FASEB J. 2006; publ. online Sept. 11th 2006.
107. Wenk HN, Brederson JD, Honda CN. Morphine directly inhibits nociceptors in inflamed skin. J Neurophysiol. 2006;95:2083-2097.
108. Wenzel RR, Zbinden S, Noll G, et al. Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide. Br J Clin Pharmacol. 1998;45:441-446.
109. Wiesner-Menzel L, Schulz B, Vakilzadeh F, et al. Electron microscopal evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol. 1981;61:465-469.
110. Wilkinson JD, Williamson EM. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatol Sci. 2007;45:87-92.
111. Wu ZZ, Chen SR, Pan HL. Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calcium-dependent calcineurin in sensory neurons. J Biol Chem. 2005;280:18142-51.
112. Zhang J, Hoffert C, Vu HK, et al. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci. 2003;17:2750-2754.
113. Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J. 2005;24:4211-4223.
114. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400:452-457.
115. Zylka MJ. Nonpeptidergic circuits feel your pain. Neuron. 47:771-772
116. (Comment on: Neuron. 2005;47:787-793.
117. Zylka MJ, Rice FL, Anderson DJ. Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd. Neuron. 2005;45:17-25.